AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
Swedencare publ AB (SS:SECARE)
46.5 SEK
+0.300 0.649%| Previous Close (in SEK) | 46.2 |
|---|---|
| Change | +0.300 0.649% |
| 52 W H/L (in SEK) | 68.829/37.380 |
| EBITDA (in SEK) | 508.6M |
| PE Ratio | 120.00 |
| Volume | 5306 |
| Diluted Eps TTM | 0.39 |
| Total Assets (in SEK) | 9522.1M |
|---|---|
| Total Liabilities (in SEK) | 2315.3M |
| Revenue TTM (in SEK) | 2504.2M |
| Cash (in SEK) | 237.3M |
| Market Cap (in SEK) | 7,434.789 M |
| Revenue Per Share TTM | 15.776 |
| Gross Profit TTM (in SEK) | 1056.201M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Swedencare publ AB
Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in Sweden, the United Kingdom, Rest of Europe, North America, Asia, and internationally. The company offers animal nutritional supplements, treats, and grooming products under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology under the Innovet name; and support and solutions for the veterinary community under the Stratford Animal Health name. It also provides pet health supplements under the NaturVet, VETCLASSICS, and NutriScience name; pet supplements, vitamins, dental care, ear cleaners, pilling agents, and topicals under the Pet MD name; and vet-formulated pet care products under the VetWELL name. In addition, it offers ProDen PlaqueOff powder, a solution for pet oral problems; ProDen PlaqueOff dental bones; ProDen PlaqueOff dental bites, a pet dental product; and Rx Vitamins for Pets. The company distributes its products through veterinarians, pet stores, and online. Swedencare AB (publ) was incorporated in 1993 and is headquartered in Malmö, Sweden.
Employees: 570
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Hakan Lagerberg | Chief Executive Officer | 1968 |
| 2. | Ms. Jenny Graflind | Chief Financial Officer | 1976 |
| 3. | Mr. Renato della Valle | Chief Executive Officer of Innovet Italia Srl | NA |
| 4. | Mr. Martin Shimko | CEO of Swedencare USA Inc. & CEO of Swedencare Tillverka Inc. | 1964 |
| 5. | Mr. John Leonard | Chief Executive officer of Swedencare UK Ltd & Swedencare Ireland Ltd | 1965 |
| 6. | Mr. Edward Holden | Chief Executive Officer of Pet MD Brands LLC | 1981 |
| 7. | Mr. Tim Ackerman | Chief Executive Officer of Fulfillment Advantage Ventures Inc | NA |
| 8. | Mr. John Kane | Chief Executive Officer of Vetio Animal Health | NA |
| 9. | Chris Jones | Chief Executive Officer of Nutravet UK Ltd | NA |
| 10. | Geoff Granger | Chief Executive Officer of NaturVet | NA |
Peers
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
| Company | Change (SEK) | Price (SEK) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
SOBI
Swedish Orphan Biovitrum AB (publ) |
+0.600 0.185% | 324 | 31.850 | 21.459 | 4.391 | 3.020 | 5.084 | 13.974 |
|
PROB
Probi AB |
+5.000 1.845% | 277 | 279.380 | 0.000 | 4.898 | 2.249 | 4.455 | 24.681 |
|
MOB
Moberg Pharma AB (publ) |
+0.850 5.965% | 14.48 | 0.000 | 0.000 | 134.993 | 0.716 | 69.672 | -7.452 |
|
ENZY
Enzymatica publ AB |
+0.020 1.117% | 1.79 | 0.000 | 66.667 | 9.666 | 6.220 | 10.142 | -10.602 |
Income Statement
(Currency in SEK)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Income Before Tax | 81M | 80.089M | 56.901M | 58.67M | 36.69M |
| Minority Interest | - | - | - | - | - |
| Net Income | 58.6M | 94.5M | 54.622M | 48.531M | 29.913M |
| Selling General Administrative | - | 281.144M | 149.846M | 43.623M | 25.19M |
| Gross Profit | 164.8M | 1015.575M | 385.872M | 157.344M | 93.051M |
| Reconciled Depreciation | 307.952M | 269.252M | 72.942M | 4.838M | 3.152M |
| Ebit | 164.8M | 123.311M | 64.793M | 51.755M | 36.92M |
| Ebitda | 474.6M | 392.447M | 137.616M | 65.21M | 40.072M |
| Depreciation And Amortization | 309.8M | 269.136M | 72.823M | 13.455M | 3.152M |
| Operating Income | 164.8M | 119.97M | 64.555M | 60.366M | 36.914M |
| Other Operating Expenses | 2159.8M | 1709.371M | 708.534M | 179.923M | 90.495M |
| Interest Expense | 93.4M | 40.527M | 7.654M | 1.696M | 0.224M |
| Tax Provision | -16.962M | -14.362M | 2.279M | 10.139M | 6.777M |
| Interest Income | 1.8M | 0.293M | 7.654M | 1.696M | 0.224M |
| Net Interest Income | -83.034M | -40.234M | -7.654M | -1.696M | -0.224M |
| Income Tax Expense | 22.5M | -14.362M | 2.279M | 10.139M | 6.777M |
| Total Revenue | 2324.6M | 1829.457M | 770.441M | 239.946M | 126.874M |
| Total Operating Expenses | 1117.6M | 895.489M | 323.965M | 97.321M | 56.672M |
| Cost Of Revenue | 2159.8M | 813.882M | 384.569M | 82.602M | 33.823M |
| Total Other Income Expense Net | -83.8M | -39.881M | -7.654M | -1.696M | -0.224M |
| Net Income From Continuing Ops | 87.351M | 94.451M | 54.622M | 48.531M | 29.913M |
| Net Income Applicable To Common Shares | - | 94.451M | 54.622M | 33.354M | 29.913M |
Balance Sheet
(Currency in SEK)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 9522.1M | 10004.662M | 3471.119M | 1150.48M | 149.447M |
| Intangible Assets | 3941.6M | 4301.947M | 1302.843M | 141.413M | 3.02M |
| Other Current Assets | 60.1M | 12.312M | 47.08M | 5.081M | 2.139M |
| Total Liab | 2315.3M | 2543.971M | 1051.319M | 217.532M | 18.119M |
| Total Stockholder Equity | 7206.8M | 7460.691M | 2419.8M | 932.948M | 131.328M |
| Other Current Liab | 100.8M | 200.043M | 60.341M | 19.786M | 8.601M |
| Common Stock | 1.6M | 1.587M | 1.182M | 1.044M | 0.79M |
| Capital Stock | 1.6M | 1.587M | 1.182M | 1.044M | 0.79M |
| Retained Earnings | 226.3M | 203.303M | 140.473M | 66.958M | 82.009M |
| Good Will | 3967.5M | 4067.474M | 1464.39M | 567.915M | 49.14M |
| Other Assets | - | 71.603M | 4.853M | 1.601M | 1.055M |
| Cash | 237.3M | 245.068M | 136.086M | 284.081M | 45.737M |
| Cash And Equivalents | - | 245.068M | 136.086M | 284.081M | 45.737M |
| Total Current Liabilities | 298M | 310.036M | 114.782M | 78.6M | 16.158M |
| Current Deferred Revenue | 75.6M | 3.263M | 0.365M | 0.047M | 0.579M |
| Net Debt | 1421.3M | 1661.294M | 585.447M | -105.373M | -42.232M |
| Short Term Debt | 37.8M | 39.84M | 17.814M | 39.776M | 1.544M |
| Short Long Term Debt | - | - | 0M | 35.5M | 0M |
| Short Long Term Debt Total | 1658.6M | 1906.362M | 721.533M | 178.708M | 3.505M |
| Other Stockholder Equity | 6209.6M | 6006.325M | 2141.723M | 864.946M | 48.507M |
| Property Plant Equipment | - | 555.767M | 247.297M | 41.072M | 15.628M |
| Total Current Assets | 992.1M | 1006.812M | 451.736M | 400.015M | 80.604M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | - | -0.815M | - | - | - |
| Net Receivables | 296.6M | 307.9M | 157.351M | 54.142M | 19.572M |
| Long Term Debt | 1445.9M | 1645.156M | 616.97M | 117.5M | 0M |
| Inventory | 398.1M | 441.532M | 158.299M | 61.792M | 15.295M |
| Accounts Payable | 83.8M | 66.89M | 36.262M | 18.991M | 5.434M |
| Accumulated Other Comprehensive Income | 769.3M | 1249.476M | 136.422M | -50.434M | 0.022M |
| Non Currrent Assets Other | -0.2M | 1.059M | 0.273M | 0.06M | 0.061M |
| Non Current Assets Total | 8530M | 8997.85M | 3019.383M | 750.465M | 68.843M |
| Capital Lease Obligations | 217.4M | 261.206M | 104.563M | 25.708M | 3.505M |
| Long Term Debt Total | - | 1862.334M | 703.719M | 117.5M | 0M |
Cash Flow
(Currency in SEK)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Investments | -287.552M | -4666.252M | -1868.745M | -619.656M | -5.113M |
| Total Cashflows From Investing Activities | - | -4666.252M | -1868.745M | -619.656M | -5.113M |
| Total Cash From Financing Activities | -271.6M | 4494.555M | 1587.849M | 821.498M | -10.774M |
| Net Income | 58.6M | 119.97M | 56.901M | 58.67M | 36.69M |
| Change In Cash | -7.768M | 108.982M | -147.995M | 238.344M | 17.302M |
| Begin Period Cash Flow | 245.068M | 136.086M | 284.081M | 45.737M | 28.435M |
| End Period Cash Flow | 237.3M | 245.068M | 136.086M | 284.081M | 45.737M |
| Total Cash From Operating Activities | 444M | 260.202M | 125.846M | 36.502M | 33.128M |
| Depreciation | 309.8M | 269.252M | 72.942M | 4.838M | 3.152M |
| Other Cashflows From Investing Activities | - | -4591.562M | -1840.963M | -618.679M | - |
| Dividends Paid | 34.9M | 31.622M | 16.944M | 11.061M | 11.061M |
| Change To Inventory | 31M | -41.517M | -17.72M | -8.093M | -3.181M |
| Sale Purchase Of Stock | - | 3533.583M | 1149.307M | 682.406M | - |
| Other Cashflows From Financing Activities | -36.2M | 1002.629M | 468.486M | 162.153M | -1.774M |
| Capital Expenditures | 36.1M | 74.69M | 27.782M | 0.977M | 5.113M |
| Change In Working Capital | 59.5M | -90.78M | -21.177M | -18.421M | -0.624M |
| Other Non Cash Items | 16.1M | -38.24M | 17.18M | -3.747M | -6.09M |
| Free Cash Flow | 407.9M | 185.512M | 98.064M | 35.525M | 28.015M |
No data found
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Related Articles
Loading...